Qiagen N.V. (QGEN): Price and Financial Metrics


Qiagen N.V. (QGEN): $52.22

0.60 (+1.16%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add QGEN to Watchlist
Sign Up

Industry: Biotech


Ranked

of 498

in industry

QGEN POWR Grades


  • QGEN scores best on the Value dimension, with a Value rank ahead of 86.21% of US stocks.
  • The strongest trend for QGEN is in Quality, which has been heading up over the past 31 weeks.
  • QGEN ranks lowest in Momentum; there it ranks in the 34th percentile.

QGEN Stock Summary

  • QGEN has a market capitalization of $11,915,392,980 -- more than approximately 83.11% of US stocks.
  • Over the past twelve months, QGEN has reported earnings growth of 115.18%, putting it ahead of 85.38% of US stocks in our set.
  • In terms of volatility of its share price, QGEN is more volatile than merely 3.85% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to Qiagen Nv, a group of peers worth examining would be SNA, PNR, TTC, ACGL, and BLD.
  • QGEN's SEC filings can be seen here. And to visit Qiagen Nv's official web site, go to www.qiagen.com.

QGEN Valuation Summary

  • QGEN's price/earnings ratio is 26.8; this is 21.18% lower than that of the median Healthcare stock.
  • QGEN's price/sales ratio has moved down 4.3 over the prior 238 months.
  • QGEN's price/sales ratio has moved down 4.3 over the prior 238 months.

Below are key valuation metrics over time for QGEN.

Stock Date P/S P/B P/E EV/EBIT
QGEN 2017-06-23 6.0 3.4 97.9 85.9
QGEN 2016-07-19 4.1 2.0 42.5 36.9
QGEN 2016-06-13 3.9 1.9 40.8 35.6
QGEN 2016-02-08 3.7 1.9 37.6 32.6
QGEN 2012-11-28 3.5 1.6 47.9 44.9
QGEN 2005-07-25 5.0 4.7 37.3 23.5

QGEN Stock Price Chart Interactive Chart >

Price chart for QGEN

QGEN Price/Volume Stats

Current price $52.22 52-week high $59.00
Prev. close $51.62 52-week low $45.33
Day low $51.97 Volume 798,300
Day high $52.45 Avg. volume 812,047
50-day MA $48.66 Dividend yield N/A
200-day MA $50.09 Market Cap 11.91B

Qiagen N.V. (QGEN) Company Bio


QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.

QGEN Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$52.22$22.17 -54%

Below please find a table outlining a discounted cash flow forecast for QGEN, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Qiagen Nv ranked in the 34th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 53.5%. In terms of the factors that were most noteworthy in this DCF analysis for QGEN, they are:

  • QGEN's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 26.29% of tickers in our DCF set.
  • Qiagen Nv's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at 9.38. This coverage rate is greater than that of 69.44% of stocks we're observing for the purpose of forecasting via discounted cash flows.
  • The weighted average cost of capital for the company is 9. This value is greater than merely 20.2% stocks in the Healthcare sector that generate free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-55%
1%-54%
2%-54%
3%-53%
4%-53%
5%-52%

IDXX, DXCM, GSK, JNJ, and NUVA can be thought of as valuation peers to QGEN, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.


QGEN Latest News Stream


Event/Time News Detail
Loading, please wait...

QGEN Latest Social Stream


Loading social stream, please wait...

View Full QGEN Social Stream

Latest QGEN News From Around the Web

Below are the latest news stories about Qiagen Nv that investors may wish to consider to help them evaluate QGEN as an investment opportunity.

Qiagen Q2 2021 Earnings Preview

No summary available.

Seeking Alpha | July 28, 2021

Genomics Market Expected To Be Worth US$ 49,996.15 million by 2027 with Business Market Insights: Eurofins Scientific, QIAGEN, BGI, Illumina, Inc., Danaher

The Genomics Market was valued at US$ 19,084.74 million in 2019 and is projected to reach US$ 49,996.15 million by 2027; it is expected to grow at a CAGR of 13.1% from 2020 to 2027. Genomic sequencing is rapidly transitioning into

OpenPR | July 28, 2021

QIAGEN N.V. deutsch

QIAGEN N.V. deutsch. QIAGEN N.V., NL0012169213

Ad Hoc News | July 27, 2021

Genomic Biomarker Market Size, Key Opportunities, Strategic Assessment, Strong Revenue | Oprating Vendors: Bio-Rad, Beckman Coulter, Myriad Genetics, Thermo Fisher Scientific, Roche, QIAGEN, Epigen

The documented report on Global Genomic Biomarker Market by Reports Globe aims to offer an organized and methodical strategy for important aspects that have affected the market in recent years and future market opportunities that companies can trust. It gives readers clear market research for better judgment and better decision making on whether or not []

Jumbo News | July 25, 2021

Polymerase Chain Reaction Market Size, Key Opportunities, Strategic Assessment, Strong Revenue | Oprating Vendors: Bio-Rad Laboratories, QIAGEN, F. Hoffmann-La Roche, Thermo Fisher Scientific, bioM

The documented report on Global Polymerase Chain Reaction Market by Reports Globe aims to offer an organized and methodical strategy for important aspects that have affected the market in recent years and future market opportunities that companies can trust. It gives readers clear market research for better judgment and better decision making on whether or []

Jumbo News | July 25, 2021

Read More 'QGEN' Stories Here

QGEN Price Returns

1-mo 7.94%
3-mo 8.50%
6-mo -3.56%
1-year 3.61%
3-year 44.57%
5-year 87.63%
YTD -1.19%
2020 56.36%
2019 -1.89%
2018 11.38%
2017 6.30%
2016 1.34%

Continue Researching QGEN

Here are a few links from around the web to help you further your research on Qiagen Nv's stock as an investment opportunity:

Qiagen Nv (QGEN) Stock Price | Nasdaq
Qiagen Nv (QGEN) Stock Quote, History and News - Yahoo Finance
Qiagen Nv (QGEN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8169 seconds.